Since p38 is a ubiquitous protein, treatment of gliomas with p38 MAPK inhibitors may be successful, however, the involvement of this pathway in multiple cellular processes may result in ambiguous effects. The gene discussed is MAPK14; the disease is central nervous system cancer.